In human hepatoma cell line HepG2 and HEK-293, BBR increased the expression of the LDL receptor (LDLR) and its half-life via the JNK/c-jun pathway and stabilized its mRNA by extracellular signal-regulated kinase (ERK) modulation [22,47]. The gene discussed is LDLR; the disease is hepatocellular carcinoma.